To achieve long-term capital and income growth through investing principally in UK equities.
Name | % Net Assets |
---|---|
Royal Dutch Shell | 7.4% |
BP | 6.5% |
VODAFONE GROUP | 6.2% |
GlaxoSmithKline | 6.1% |
BRITISH AMERICAN TOBACCO | 4.2% |
ASTRAZENECA PLC | 4.0% |
HSBC HLDGS | 3.9% |
Sage Group | 2.7% |
CENTRICA PLC | 2.4% |
BG GROUP | 2.3% |
Key | % Net Assets |
---|---|
Royal Dutch Shell | 7.4% |
BP | 6.5% |
VODAFONE GROUP | 6.2% |
GlaxoSmithKline | 6.1% |
Other | 73.8% |
Date | 23-Nov-2023 |
---|---|
NAV | 88.50p |
Currency | GBP |
Change | -0.23p |
% | -0.26% |
YTD change | 88.50p |
YTD % | n/a |
Fund Inception | 17/11/1997 |
---|---|
Fund Manager | n/a |
TER | 1.77 (31-Oct-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.12 |
You are here: research